Jamie has worked with Corvus since 2007 and has led a number of reverse takeover transactions, stock market listings, initial public offerings, secondary fundraisings, and merger transactions. Jamie's prior transaction experience includes advising several special purpose acquisition vehicles in listing on the London Stock Exchange, including the listing of Bermele Plc, a special purpose acquisition vehicle, and the subsequent acquisition of Bermele by East Imperial Pte. Ltd., a global purveyor of ultra-premium beverages, in June 2019; the listing of Leverett Plc, which subsequently acquired Nuformix Plc, a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing; and Cizzle Biotechnology Holdings Plc, a UK-based diagnostics developer. Jamie graduated from the University of Bristol with a BSc in Economics & Finance.